MAY - 20226Managing EditorAlex D'souzaEditorial StaffVisualizerDavid JohnMichael WayneSalesAndrew D'Souzaandrew.dsouza@medicaltechoutlook.com510.996.5123Joshua Parker Merlin WatsonJoe Philip Laura PintoMAY - 09 - 2022, volume 05 - Issue 19 (ISSN 2691-4093) Published by ValleyMedia, Inc. Emailsales@medicaltechoutlook.comeditor@medicaltechoutlook.commarketing@medicaltechoutlook.comTo subscribe to Medical Tech OutlookVisit www.medicaltechoutlook.com Copyright © 2022 ValleyMedia Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.*Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffAlex D'souzaManaging Editoreditor@medicaltechoutlook.comIn Vitro diagnostics (IVDs) are a critical component of modern medicine. As in-vitro diagnostics involves testing of various biological samples, it aids the diagnosis of infectious diseases such as COVID-19 they are critical in the fight against the virus, which has a high probability of developing new strains. According to the European Cardiovascular Disease Statistics, each year 3.9 million individuals die from cardiovascular disorders. And from this, a staggering 1.8 million people die in the EU. These statistics have motivated patients to seek an early diagnosis of their illness, resulting in an increase in the usage of IVD test kits.By enabling earlier and more focused therapies IVD's minimize hospitalizations and convalescences, leading to healthier populations, lower expenses, and increased economic growth over the long haul. In Vitro diagnostic services are witnessing a change from traditional to a new generation of diagnostics that work at the gene level. Polymerase chain reaction (PCR), microarray methods, sequencing technology, and mass spectrometry are some of the important technologies utilized in In Vitro diagnostics for test sample preparation. Clinical chemistry, tissue diagnostics, immunodiagnostics, hematology, and other methods are also employed to accomplish In Vitro diagnosis.In this edition of MedTech Outlook Europe, we bring you the story of some of the most successful in vitro diagnostic solution providers in Europe that deliver the best outcomes for their clients. This edition also offers a combination of thought leadership from subject matter experts with real-life stories on fostering robust partnerships and exclusive insights from CIOs and CXOs. We hope this edition will help you choose the right in vitro diagnostic solution provider according to your requirements.Aiding In The Early Detection of Diseases Sarah FernandesEDITORIAL
< Page 5 | Page 7 >